Evidence map›Paper›PMID 8551577›Full record

ArticleJournal of virology1996

SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element.

L M McNally, M T McNally

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  6. Article
  7. Article
  8. RNA processing control in avian retroviruses.Frontiers in bioscience : a journal and virtual library · 2008
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. SRp30c is a repressor of 3' splice site utilization.Molecular and cellular biology · 2002
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

L M McNallyDepartment of Microbiology, Medical College of Wisconsin, Milwaukee 53226, USA.
M T McNally
Medical College of Wisconsin · US

Funding

RETROVIRAL REGULATORY SEQUENCES WITHIN CODING SEQUENCESR01CA048746 · NCI · JOHNS HOPKINS UNIVERSITY · PI BEEMON, KAREN L. · 1989 to 2014
$4.6M
Retroviral Regulatory Sequences within Coding SequencesR56CA048746 · NCI · JOHNS HOPKINS UNIVERSITY · PI BEEMON, KAREN L. · 2008 to 2008
$317k
NCI NIH HHS CA48746
6 · The paper itself

Abstract

Retroviral replication requires that a portion of the primary transcripts generated from proviral DNA be spliced to serve as mRNA for the envelope protein and in Rous sarcoma virus as src mRNA. However, a substantial amount of full-length RNA must be maintained in an unspliced form, as the unspliced RNA serves both as mRNA for structural proteins and virion-associated enzymatic proteins and as genomic RNA for progeny virions. The extent of viral RNA splicing must be finely controlled, since only a narrow range in the ratio of unspliced RNA to spliced RNA is tolerated for optimal replication. A number of cis-acting sequences within the RNA of Rous sarcoma virus play a role in preserving a large pool of unspliced RNA. One such sequence, the negative regulator of splicing (NRS), is of interest because it blocks splicing but is not located near any of the splice junctions. To better understand how this novel element blocks splicing at a distance, we set out to identify host cell factors that interact specifically with this inhibitory sequence. In this study, proteins from nuclear extracts with molecular masses of 26, 36, 44, and 55 kDa were shown by UV cross-linking assays to bind the NRS preferentially. One of them, p55, was also detected in a specific complex with SR protein electrophoretic mobility shift assay. All but p55 have biochemical properties consistent with SR protein splicing factors, and some, but not all, of the total SR proteins purified from HeLa cells cross-link specifically to the NRS. The strongest cross-linking SR protein is SRp30a/b, which is composed of the splicing factors SF2/ASF and SC35. The NRS specifically binds bacterially expressed SF2/ASF, whereas nonfunctional mutants do not. Data indicating that the 36-kDa protein which cross-links in nuclear extracts is SF2/ASF are presented. The data indicate that factors normally required for RNA splicing may be exploited by retroviruses to block splicing.

Indexed as

RNA SplicingAvian Sarcoma VirusesBase SequenceBinding SitesCross-Linking ReagentsHeLa CellsHumansMolecular Sequence DataNuclear ProteinsPhosphoproteinsPurinesRNA-Binding ProteinsRNA, ViralSerine-Arginine Splicing FactorsUltraviolet RaysCross-Linking ReagentsNuclear ProteinsPhosphoproteinspurinePurinesRNA-Binding ProteinsRNA, ViralSerine-Arginine Splicing Factors

Identifiers

PMID8551577
PMCPMC189925
OpenAlexW2121566878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.